Workflow
MMR II vaccine
icon
Search documents
Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update
Globenewswire· 2025-08-14 20:30
Core Viewpoint - Callan JMB Inc. has made significant strides in expanding its logistics services for the healthcare sector, including forming strategic partnerships, launching international operations, and enhancing emergency preparedness capabilities, positioning itself for sustained growth in high-demand markets [2][3]. Business Highlights - A strategic partnership was formed with Revival Health Inc. to create an integrated supply chain infrastructure for health, wellness, and longevity products, enhancing distribution capabilities [2][3]. - The company launched a subsidiary in India, establishing a temperature-controlled warehouse in Pune for pharmaceutical storage and distribution, and has secured agreements with local companies to facilitate U.S. market entry [2][3]. - Callan JMB extended its emergency preparedness contract with the City of Chicago through June 2026, increasing total contract value to $9.1 million with an additional $1.5 million in funding [2][3]. - Christopher Shields was appointed as Senior Vice President for Emergency Preparedness & Response/Government Affairs to expand operations into new markets [2][3]. - The company successfully redistributed over 1,300 MMR II vaccine doses during a measles outbreak response, demonstrating its logistical efficiency and sustainability [2][3]. Financial Highlights - For the three months ended June 30, 2025, revenues were $1.7 million, a decrease from $2.0 million in the same period last year, attributed to reduced demand for emergency preparedness services [8][10]. - Gross profit for the same period was $0.6 million, down from $1.0 million year-over-year [8][11]. - Selling, general, and administrative expenses increased to $2.0 million for the quarter, primarily due to costs associated with being a public entity and new senior staff hires [8][11]. - The net loss for the three months ended June 30, 2025, was $1.4 million, compared to a loss of $0.1 million in the prior year [8][11]. - Cash and cash equivalents as of June 30, 2025, were $4.2 million, an increase from $2.1 million at the end of the previous year [8][13].
Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines
Globenewswire· 2025-06-05 13:00
Core Insights - Callan JMB redistributed over 1,300 doses of the MMR II vaccine from Chicago to Texas and New Mexico to combat measles outbreaks, ensuring no vaccines were wasted [1][2] - The company utilized specialized cold chain reusable shippers with active temperature monitoring to maintain required temperatures during transit, and all shippers were recovered and recertified for reuse [3][4] - The operation exemplified effective collaboration between public health departments across states to ensure critical medications reach communities during outbreak responses [4] Company Overview - Callan JMB Inc. is an integrative logistics company that supports the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [5] - The company emphasizes its expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, aiming to provide a gold standard in client experience and environmental sustainability [5]